William Geist Power - 15 Aug 2026 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
02 Nov 2026, 16:36:10 UTC
Original report date
18 Aug 2026
Prior SEC filing
05 Nov 2025
Next SEC filing
19 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Filing notes and source

Key filing fact

William Geist Power filed Form 4/A - Amendment for BIO-TECHNE Corp (TECH) on 02 Nov 2026.

Key facts

  • This page summarizes William Geist Power's Form 4/A - Amendment filing for BIO-TECHNE Corp (TECH).
  • 7 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2026, 16:36.

Change

  • Previous filing in this sequence was filed on 05 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001832210 Primary reporting owner

Geist William

Relationship
PRESIDENT, PROTEIN SCIENCES
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,547
Change %
+32%
Price
$0.000000*
Shares after
27,050
Date
15 Aug 2026
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
Shares
-2,019
Change %
-7.5%
Price
$72.40*
Shares after
25,031
Date
15 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Performance Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-22,545
Change %
-92%
Price
$0.000000*
Shares after
1,879
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,545
Exercise price
$84.61
Footnotes
F1
TECH transaction Derivative

Performance Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-698
Change %
-7.7%
Price
$0.000000*
Shares after
8,376
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
698
Exercise price
Footnotes
F2, F3
TECH transaction Derivative

Performance Restricted Stock Units

Options Exercise

Transaction value
Shares
-8,376
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,376
Exercise price
Footnotes
F2, F3
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,623
Change %
-50%
Price
$0.000000*
Shares after
2,623
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,623
Exercise price
Footnotes
F2, F4
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,226
Change %
-33%
Price
$0.000000*
Shares after
6,452
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,226
Exercise price
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F3

On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited.

Footnote F4

2,623 restricted stock units vest on 8/15/2027.

Footnote F5

3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .